NCT01174810: Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study
- State
- State not given
- Phase
- Phase 2
- People
- 40 planned
- Started
- Jul 2010
- Primary completion
- Mar 2013
- Arms
- Exenatide
- Results
- None posted
- 4 Aug 2010: Trial registered
A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set
Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 3 registered trials.
Kind of treatment: Drug.
Also known as Bydureon, Bydureon bcise, Byetta, Exenatide once weekly (EQW ).
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.